Search research articles
Contact Us
Filters
Showing results (31-40 of 93) with videos related to
Page
of 10
Sort By:
Journal of Neuro-Oncology
|
November 10, 2016
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma
Edward Pan, Jeffrey G Supko, Thomas J Kaley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2018
Associations of anticoagulant use with outcome in newly diagnosed glioblastoma
Emilie Le Rhun, Els Genbrugge, Roger Stupp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2007
Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study
Wei Chen, Sibylle Delaloye, Daniel H S Silverman, et al.
Cancer Chemotherapy and Pharmacology
|
August 19, 2007
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study
Michael D Prados, W K A Yung, Patrick Y Wen, et al.
Cancer Chemotherapy and Pharmacology
|
October 11, 2011
Pharmacokinetic drug interaction between AEE788 and RAD001 causing thrombocytopenia in patients with glioblastoma
David A Reardon, Timothy Cloughesy, Jeremy Rich, et al.
Current Oncology (Toronto, Ont.)
|
October 28, 2025
Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma
Anna F Piotrowski, Kent Shih, Pierre Giglio, et al.
Brain Pathology (Zurich, Switzerland)
|
December 18, 2009
Genomic landscape of meningiomas
Yohan Lee, Jason Liu, Shilpa Patel, et al.
Journal of Neuro-Oncology
|
July 9, 2011
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery
Mark R Gilbert, John Kuhn, Kathleen R Lamborn, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
November 13, 2008
A tool for improving the longitudinal imaging characterization for neuro-oncology cases
Ricky K Taira, Ricky Taira, Alex Bui, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2010
Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas
Barbara J Fueger, Johannes Czernin, Timothy Cloughesy, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 93) with videos related to
Sort By:
Page
of 10
Journal of Neuro-Oncology
|
November 10, 2016
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma
Edward Pan, Jeffrey G Supko, Thomas J Kaley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2018
Associations of anticoagulant use with outcome in newly diagnosed glioblastoma
Emilie Le Rhun, Els Genbrugge, Roger Stupp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2007
Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study
Wei Chen, Sibylle Delaloye, Daniel H S Silverman, et al.
Cancer Chemotherapy and Pharmacology
|
August 19, 2007
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study
Michael D Prados, W K A Yung, Patrick Y Wen, et al.
Cancer Chemotherapy and Pharmacology
|
October 11, 2011
Pharmacokinetic drug interaction between AEE788 and RAD001 causing thrombocytopenia in patients with glioblastoma
David A Reardon, Timothy Cloughesy, Jeremy Rich, et al.
Current Oncology (Toronto, Ont.)
|
October 28, 2025
Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma
Anna F Piotrowski, Kent Shih, Pierre Giglio, et al.
Brain Pathology (Zurich, Switzerland)
|
December 18, 2009
Genomic landscape of meningiomas
Yohan Lee, Jason Liu, Shilpa Patel, et al.
Journal of Neuro-Oncology
|
July 9, 2011
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery
Mark R Gilbert, John Kuhn, Kathleen R Lamborn, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
November 13, 2008
A tool for improving the longitudinal imaging characterization for neuro-oncology cases
Ricky K Taira, Ricky Taira, Alex Bui, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2010
Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas
Barbara J Fueger, Johannes Czernin, Timothy Cloughesy, et al.
Page
of 10